BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29086018)

  • 1. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
    J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
    J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S
    J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Bozovic I; Kacar A; Cobeljic M; Dejanovic I; Stevic Z; Basta I
    J Peripher Nerv Syst; 2019 Jun; 24(2):180-186. PubMed ID: 30973184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Merkies IS; Kieseier BC
    Eur Neurol; 2016; 75(3-4):199-206. PubMed ID: 27077919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients with multifocal motor neuropathy from Serbia.
    Bozovic I; Peric S; Basta I; Kacar A; Nikolic A; Belanovic B; Lavrnic D; Rakocevic-Stojanovic V; Stevic Z
    J Neurol Sci; 2019 Apr; 399():151-154. PubMed ID: 30818075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registry.
    Mork H; Motte J; Fisse AL; Grüter T; Brünger J; Stoykova Z; Bulut Y; Athanasopoulos D; Sturm D; Tegenthoff M; Gold R; Enax-Krumova E; Pitarokoili K
    Eur J Neurol; 2022 Jul; 29(7):2109-2120. PubMed ID: 35357725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I
    Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with polyneuropathy associated with different types of monoclonal gammopathy of undetermined significance.
    Opalic M; Peric S; Palibrk A; Bozovic I; Bjelica B; Stevic Z; Basta I
    Acta Neurol Belg; 2020 Oct; 120(5):1133-1138. PubMed ID: 31201672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.
    Garssen MP; Bussmann JB; Schmitz PI; Zandbergen A; Welter TG; Merkies IS; Stam HJ; van Doorn PA
    Neurology; 2004 Dec; 63(12):2393-5. PubMed ID: 15623709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
    Merkies IS; Hughes RA; Donofrio P; Bril V; Dalakas MC; Hanna K; Hartung HP; Latov N; van Doorn PA; Deng C;
    J Peripher Nerv Syst; 2010 Sep; 15(3):208-15. PubMed ID: 21040143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran.
    Okhovat AA; Gholamalizadeh S; Nafissi S; Fatehi F
    J Clin Neuromuscul Dis; 2019 Dec; 21(2):77-83. PubMed ID: 31743250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
    van Veen R; Pallada G; Wieske L; Ten Holter SEM; van Rootselaar AF; Verhamme C; de Bie RMA; van Schaik IN; Merkies ISJ; Dijk JM; Eftimov F
    J Peripher Nerv Syst; 2023 Mar; 28(1):58-68. PubMed ID: 36571466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
    Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy.
    Klehmet J; Tackenberg B; Haas J; Kieseier BC
    BMC Neurol; 2023 May; 23(1):207. PubMed ID: 37237267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of environmental factors and physical activity on disability and quality of life in CIDP.
    Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Beghi E; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Schenone A; Liberatore G; Peci E; Spina E; Tronci S; Cotti Piccinelli S; Toscano A; Gentile L; Piccolo L; Leonardi L; Mataluni G; Ruiz M; Sabatelli M; Santoro L; Nobile-Orazio E;
    J Neurol; 2020 Sep; 267(9):2683-2691. PubMed ID: 32430573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy.
    Lawley A; Abbas A; Seri S; Rajabally YA
    Muscle Nerve; 2020 Aug; 62(2):226-232. PubMed ID: 32388856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in chronic inflammatory demyelinating polyneuropathy.
    Gable KL; Attarian H; Allen JA
    Muscle Nerve; 2020 Dec; 62(6):673-680. PubMed ID: 32710648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.